Let's debunk the hype: publishing a research article on arXiv does nothing to change the actual cash flow for obtaining Series A funding.
For venture capital actors, what matters are the concrete evidence of traction and viability of a company, not theoretical models, no matter how sophisticated.
The AMF, for example, would require independent audits and robust empirical validation before such a framework influences investment decisions.
Without this, a model like MIRAGE-VC remains an intellectual exercise, lacking persuasive power over an investor.
For example, a success prediction without understanding the risks specific to a project will be ignored.